World Rank
#734,652
Ultragenyx.com
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Visits & Engagement
On PC & mobile, in the last 6 months
Engagements
February, 2025
| Overall Visits | 39.31K |
| Time On Site | 00:02:46 |
| Pages per Visit | 2.59 |
| Bounce Rate | 44.93% |
Traffic Sources
On PC, in the last 3 months. Click on the column for drilldown
Geography
On PC, in the last month
Traffic by countries
| United States | |
| India | |
| United Kingdom | |
| Japan | |
| Canada |
Review
By popularity Ultragenyx.com ranked 734 652th in the World, 230 343th place in United States, 211th place in category "Health / Biotechnology and Pharmaceuticals"
Has clear positive dynamics in attracting traffic. In the period from december'24 to february'25 the attendance of this site increased from 22 687 to 39 967 (+55.16%).
For February '2025 there were 39 309 visits. The average visitor per session views 2.59 page(s) and spends 2 minute(s) 46 second(s) on the site. At the same time the bounce rate is 44.93%.
The most popular site uses in United States, attracting from this country 82.55% of overall traffic.
Structure of traffic sources: the highest traffic "Search" (48.18%), the second most important "Direct" (43.57%), followed by "Referrals" (6.44%), then "Social" (0.91%), then "Display Ads" (0.79%) and in the last place "Mail" with a share 0.08%.
Referrals
6.44%
Top Referring Sites:
No Data Available
Top Destination Sites:
No Data Available
Search
48.18%
Organic Keywords:
No Data Available
Paid Keywords:
No Data Available
Social Networks
0.91%
Display Advertising
0.79 %
Top Publishers
No Data Available
Audience Interests
Also visited websites
No Data Available